The economic and health impact of UK CEiRSI: the UK Centre of Excellence for In-Silico Regulatory Science and Innovation

Brittany Darrow, Paul Oyalo, Phill O’Neill, Matthew Napier, Matthias Hofer, Amanda Cole and Graham Cookson

Grant-Funded Research from Office of Health Economics

Abstract: Investing in the UK Centre of Excellence for in-silico Regulatory Science & Innovation (CEiRSI) could accelerate the adoption of in-silico technologies in the UK. Doing so could improve patient access to innovation, reduce NHS costs and strengthen the UK's position as a global leader in in- silico technology and life sciences.

JEL-codes: I1 (search for similar items in EconPapers)
Date: 2026-10-21
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.ohe.org/publications/the-economic-and- ... ence-and-innovation/ (text/html)
https://www.ohe.org/wp-content/uploads/2026/10/Dar ... act-of-UK-CEiRSI.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ohe:grafun:002530

Access Statistics for this paper

More papers in Grant-Funded Research from Office of Health Economics Contact information at EDIRC.
Bibliographic data for series maintained by Publications Manager ( this e-mail address is bad, please contact ).